Novartis Raises Profit Guidance as Key Drugs Boost Sales
Wall Street Journal
Novartis raised its profit guidance a second time this year after second-quarter profit and sales rose and outpaced analysts’ expectations, boosted by revenue from its blockbuster treatments.
https://www.wsj.com/articles/novartis-raises-profit-guidance-as-key-drugs-boost-sales-d6a79f0e